Syntrix Wins $96M Verdict Against Illumina In DNA Patent Suit
A federal jury on Thursday returned a verdict for $96 million in favor of biotechnology research firm Syntrix Biosystems Inc., finding that Illumina Inc. has infringed and induced others to infringe...To view the full article, register now.
Already a subscriber? Click here to view full article